Estrogen regulation of human with-no-lysine (K) kinase-4 gene expression involves AP-1 transcription factor

Molecular and Cellular Endocrinology

Volumn 332, Issue 1-2, 2011, Pages 140-148

  Zhang, Yuanyuan ^a   Li, Chunyi ^a   Li, Wei ^a   Zhao, Yanyan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

17 Estradiol; Activator protein 1; Estrogen receptor alpha; With no lysine (K) kinase 4

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; MESSENGER RNA; PROTEIN C FOS; PROTEIN C JUN; PROTEIN KINASE WNK4; RENILLA LUCIFERIN 2 MONOOXYGENASE; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CELL STRAIN HEK293; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

BASE SEQUENCE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; GENE EXPRESSION; HEK293 CELLS; HUMANS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; PROTEIN-SERINE-THREONINE KINASES; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC;

EID: 78650520284     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.10.006     Document Type: Article

References (25)

1. Chinenov Y., Kerppola T.K. Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene 2001, 20:2438-2452. (PMID: 11402339).
2. Duan R., Porter W., Safe S. Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: role of estrogen receptor Sp1 complex formation. Endocrinology 1998, 139:1981-1990. (PMID: 9528985).
3. Duan R., Ginsburg E., Vonderhaar B.K. Estrogen stimulates transcription from the human prolactin distal promoter through AP1 and estrogen responsive elements in T47D human breast cancer cells. Mol. Cell. Endocrinol. 2008, 281:9-18. (PMID: 18022314).
4. Dubey R.K., Tofovic S.P., Jackson E.K. Cardiovascular pharmacology of estradiol metabolites. J. Pharmacol. Exp. Ther. 2004, 308:403-409. (PMID: 14657266).
5. Hall J.M., McDonnell D.P. Coregulators in nuclear estrogen receptor action: from concept to therapeutic targeting. Mol Interv. 2005, 5:343-357. (PMID: 16394250).
6. He G., Wang H.R., Huang S.K., Huang C.L. Intersectin links WNK kinases to endocytosis of ROMK1. J. Clin. Invest. 2007, 117:1078-1087. (PMID: 17380208).
7. Hockings J.K., Degner S.C., Morgan S.S., Kemp M.Q., Romagnolo D.F. Involvement of a specificity proteins-binding element in regulation of basal and estrogen-induced transcription activity of the BRCA1 gene. Breast Cancer Res. 2008, 10:R29. (PMID: 18377656).
8. Jiang Y., Ferguson W.B., Peng J.B. WNK4 enhances TRPV5-mediated calcium transport: potential role in hypercalciuria of familial hyperkalemic hypertension caused by gene mutation of WNK4. Am. J. Physiol. Renal Physiol. 2007, 292:F545-F554. (PMID: 17018846).
9. + secretion. Nat. Genet. 2003, 35:372-376. (PMID: 14608358).
10. - permeability is regulated by WNK4 kinase: insight into normal physiology and hypertension. Proc. Natl. Acad. Sci. 2004, 101:14877-14882. (PMID: 15465913).
11. Li C., Li Y., Li Y., Liu H., Sun Z., Lu J., Zhao Y. Glucocorticoid repression of human with-no-lysine (K) kinase-4 gene expression is mediated by the negative response elements in the promoter. J. Mol. Endocrinol. 2008, 40:3-12. (PMID: 18096992).
12. Li M., Zhao Y., Li Y., Li C., Chen F., Mao J., Zhang Y. Upregulation of human with-no-lysine kinase-4 gene expression by GATA-1 acetylation. Int. J. Biochem. Cell Biol. 2009, 41:872-878. (PMID: 18793746).
13. Mercuro G., Zoncu S., Saiu F., Mascia M., Melis G.B., Rosano G.M. Menopause induced by oophorectomy reveals a role of ovarian estrogen on the maintenance of pressure homeostasis. Maturitas 2004, 47:131-138. (PMID: 14757272).
14. Mitchell J.A., Lye S.J. Differential activation of the connexin 43 promoter by dimers of activator protein-1 transcription factors in myometrial cells. Endocrinology 2005, 146:2048-2054. (PMID: 15618352).
15. Petz L.N., Ziegler Y.S., Loven M.A., Nardulli A.M. Estrogen receptor alpha and activating protein-1 mediate estrogen responsiveness of the progesterone receptor gene in MCF-7 breast cancer cells. Endocrinology 2002, 143:4583-4591. (PMID: 12446585).
16. Petz L.N., Ziegler Y.S., Schultz J.R., Nardulli A.M. Fos and Jun inhibit estrogen-induced transcription of the human progesterone receptor gene through an activator protein-1 site. Mol. Endocrinol. 2004, 18:521-532. (PMID: 14684847).
17. Schulman I.H., Aranda P., Raij L., Veronesi M., Aranda F.J., Martin R. Surgical menopause increases salt sensitivity of blood pressure. Hypertension 2006, 47:1168-1174. (PMID: 16618835).
18. Srivastava S., Weitzmann M.N., Cenci S., Ross F.P., Adler S., Pacifici R. Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD. J. Clin. Invest. 1999, 104:503-513. (PMID: 10449442).
19. Teyssier C., Belguise K., Galtier F., Chalbos D. Characterization of the physical interaction between estrogen receptor alpha and JUN proteins. J. Biol. Chem. 2001, 276:36361-36369. (PMID: 11477071).
20. Umayahara Y., Kawamori R., Watada H., Imano E., Iwama N., Morishima T., Yamasaki Y., Kajimoto Y., Kamada T. Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer. J. Biol. Chem. 1994, 269:16433-16442. (PMID: 8206951).
21. Wilson F.H., Disse-Nicodeme S., Choate K.A., Ishikawa K., Nelson-Williams C., Desitter I., Gunel M., Milford D.V., Lipkin G.W., Achard J.M., Feely M.P., Dussol B., Berland Y., Unwin R.J., Mayan H., Simon D.B., Farfel Z., Jeunemaitre X., Lifton R.P. Human hypertension caused by mutations in WNK kinases. Science 2001, 293:1107-1112. (PMID: 11498583).
22. Wilson F.H., Kahle K.T., Sabath E., Lalioti M.D., Rapson A.K., Hoover R.S., Hebert S.C., Gamba G., Lifton R.P. Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na-Cl cotransporter is inhibited by wild-type but not mutant WNK4. Proc. Natl. Acad. Sci. 2003, 100:680-684. (PMID: 12515852).
23. Xu B., English J.M., Wilsbacher J.L., Stippec S., Goldsmith E.J., Cobb M.H. WNK1, a novel mammalian serine/threonine protein kinase lacking the catalytic lysine in subdomain II. J. Biol. Chem. 2000, 275:16795-16801. (PMID: 10828064).
24. Yamauchi K., Rai T., Kobayashi K., Sohara E., Suzuki T., Itoh T., Suda S., Hayama A., Sasaki S., Uchida S. Disease-causing mutant WNK4 increases paracellular chloride permeability and phosphorylates claudins. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:4690-4694. (PMID: 15070779).
25. Yang C.L., Angell J., Mitchell R., Ellison D.H. WNK kinases regulate thiazide-sensitive Na-Cl cotransport. J. Clin. Invest. 2003, 111:1039-1045. (PMID: 12671053).